1. Pink Sheet
  2. >>Advanced Technologies

Canada’s HTA Agency Reveals How To Submit AI-Driven Evidence

 
• By Neena Brizmohun

Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.

Artificial intelligence technology and pill
AI can be used to generate evidence used in applications for health technology assessments (Shutterstock)
Key Takeaways
  • Canada’s Drug Agency (CDA-AMC) has published a new position statement on the use of artificial intelligence (AI) methods in health technology assessments (HTAs).

Drug companies that are considering using artificial intelligence (AI)-informed evidence in the health technology assessment dossiers they submit in Canada...

More from AI

More from Market Access